TE_38336
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L1P2_5end |
|---|---|
| TE superfamily | L1 |
| TE class | LINE |
| Gene | - |
| Class | Intergenic |
| Coding | Non-coding, Other |
| Tumor-specific score | 204.00 |
| Counts of samples | TCGA_tumor:180; TCGA_normal:0; GTEx:0 |
| TSS | chrX(+):14974681 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_38336.1 | - | Intergenic | Non-coding | Non-coding | chrX(+):14974682,14975181,14978208,14978324,14993415,14993435 |
| teRNA_38336.2 | - | Intergenic | Non-coding | Non-coding | chrX(+):14974682,14975181,14978208,14978228 |
| teRNA_38336.3 | - | Intergenic | Non-coding | Non-coding | chrX(+):14974682,14975181,14978208,14978324,14993418,14993500,14994594,14994614 |
| teRNA_38336.4 | - | Intergenic | Non-coding | Non-coding | chrX(+):14974682,14975181,14978208,14978324,15018100,15018120 |
| teRNA_38336.5 | - | Intergenic | Non-coding | Non-coding | chrX(+):14974682,14975181,14978208,14978324,14993415,14993500,14994594,14994614 |
| teRNA_38336.6 | - | Intergenic | Non-coding | Non-coding | chrX(+):14974682,14975181,14978208,14978324,14993415,14993500,15044323,15044453,15046464,15046484 |
| teRNA_38336.7 | - | Intergenic | Non-coding | Non-coding | chrX(+):14974682,14975181,14978208,14978324,14993418,14993500,15018100,15018120 |
| teRNA_38336.8 | - | Intergenic | Non-coding | Non-coding | chrX(+):14974682,14975181,14978208,14978324,14993415,14993500,15018100,15018120 |
| teRNA_38336.9 | - | Intergenic | Non-coding | Non-coding | chrX(+):14974682,14975181,14978208,14978324,14993415,14993500,15044323,15044453,15046464,15046929,15049331,15049351 |
| teRNA_38336.10 | - | Intergenic | Other | MNPVPQLEMQKSPVFCVAHIGSCRLELFLFGHLGTSTCILWKVLPFLKKMWTLPGFFCEAGFLQVMVHDNINTSDDCAFGTFTLEAFSGSISTKYQNPRIWPLQSFQKANFAYSAHTLSHSETLPSKILTSTRDLSEGFIQR* | chrX(+):14974682,14975181,14978208,14978324,15044323,15044453,15046464,15046484 |
1
2
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
